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A B S T R A C T
The present study was designed to investigate indicators of abdominal adipose tissue lipolysis
(microdialysis), and subcutaneous adipose tissue blood flow and whole-body lipolysis, in obesity-
associated type II diabetes during overnight-fasted conditions (baseline) and during intravenous
infusion of the non-selective b-agonist isoprenaline. Basal subcutaneous adipose tissue blood flow
and isoprenaline-induced increases in adipose tissue blood flow were not signifcantly different
between subjects with type II diabetes and non-obese, non-diabetic controls. Adipose tissue
interstitial glycerol concentrations were significantly higher in subjects with type II diabetes
compared with controls (P! 0.01), and during isoprenaline infusion there was a decrease in
interstitial glycerol in both groups (P! 0.001). Arterial glycerol concentrations were higher in
subjects with type II diabetes compared with controls (P! 0.05), whereas the increases in
arterial glycerol concentration in response to isoprenaline infusion were of a similar magnitude
in the two groups. Estimated subcutaneous adipose tissue glycerol release was not significantly
different between the groups (controls and subjects with type II diabetes : baseline, fi129‡32
and fi97‡72 lmol[min−1[100 g−1 adipose tissue respectively; isoprenaline, fi231‡76 and
fi286‡98 lmol[min−1[100 g−1 respectively). Values for fat oxidation were not significantly
different between groups, whereas the isoprenaline-induced increase in fat oxidation tended to
be less pronounced in subjects with type II diabetes compared with controls (0.022‡0.008 and
0.038‡0.003 g/min respectively; Pfl 0.058). Thus estimated basal subcutaneous adipose tissue
glycerol release, expressed per unit of fat mass, is not different in controls and in subjects with
type II diabetes. Additionally, the isoprenaline-induced increases in indicators of local abdominal
subcutaneous adipose tissue, systemic lipolysis and abdominal adipose tissue blood flow
responses were comparable in obese subjects with type II diabetes and in controls. The last two
findings contrast with previous data from obese subjects, indicating that the regulation of
lipolysis may differ in obesity and obesity-associated type II diabetes.
INTRODUCTION
Abdominal obesity plays a central role in the devel-
opment of insulin resistance and type II diabetes [1].
Several pathogenic mechanisms responsible for the de-
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Abbreviations : ANOVA, analysis of variance ; NEFA, non-esterified fatty acids.
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velopment of impaired glucose metabolism and insulin
resistance can be linked to fat metabolism. First, blunted
catecholamine-induced lipolysis has been reported in
vitro in subcutaneous adipocytes from abdominally
obese males with insulin resistance or type II diabetes [2],
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and in vivo in upper-body-obese subjects before and
after weight reduction [3–5]. A factor possibly involved
in the defect in lipid mobilization in abdominal obesity is
adipose tissue blood flow, which was shown to be blunted
in obese subjects during catecholamine stimulation [6,7].
Secondly, diminished catecholamine-induced oxi-
dation of fat has been reported in obese subjects [4,5,8,9]
and in obese subjects with type II diabetes [10], which is
most probably a consequence of impaired muscle uptake
of non-esterified fatty acids (NEFA) [4,5]. The
diminished sympathetically mediated mobilization and
oxidation of fat under conditions whereby the energy
demands of the body are increased may favour the
maintenance of large fat stores, and consequently may
promote obesity and insulin resistance. It has been
suggested that the diminished NEFA uptake in muscle
may increase the supply of NEFA to the liver, thereby
promoting increased hepatic insulin resistance and in-
creased production of very-low-density lipoproteins
[11].
Thirdly, increased basal adipose tissue lipolysis and
increased circulating NEFA concentrations have been
linked to peripheral insulin resistance [12,13]. Moreover,
increased glycerol release and accelerated glycerol turn-
over may provide carbon skeletons for gluconeogenesis
in the liver, thereby stimulating hepatic glucose output
[14].
The present study intended to investigate whether the
defects in b-adrenoceptor-mediated lipolysis in obese
males previously observed in our laboratory [4,5] are also
present in obese males with type II diabetes, by com-
paring them with a non-obese control group. Indicators
of local abdominal subcutaneous lipolysis and blood flow
and whole-body lipolysis were studied during rest and
during b-adrenergic stimulation by the non-selective b-
agonist isoprenaline.
METHODS
Subjects
Subjects were eight healthy lean males (controls) and
eight obese subjects with type II diabetes of average
duration 2 years and 2 months (range 0.5–8 years). The
diabetic subjects were treated by dietary intervention
alone (n fl 2) or together with sulphonylurea (n fl 6). All
diabetic subjects had reasonable blood glucose control
[HbA
"c
(glycosylated haemoglobin) 6.4‡0.3%; range
5.6–7.8%; normal values 4.2–6.2%]. Besides sulphonyl-
ureas, no other medication was used. Medication was
stopped 2 days before the experiment. No subject had
serious health problems apart from their diabetes. A
normal resting ECG and normal blood pressure (diastolic
pressure ! 95 mmHg) were prerequisites for partici-
pation in the study. Subject characteristics are listed in
Table 1 Baseline characteristics of the subjects
Values are means‡S.E.M. (n fl 8 in each group). HbA1c, glycosylated
haemoglobin.
Subjects with type
Control subjects II diabetes
Age (years) 50.6‡2.4 51.8‡2.4
Weight (kg) 73.7‡2.6 103.6‡5.5
Height (cm) 178‡2 177‡2
Body mass index (kg/m2) 23.6‡0.7 32.6‡1.4
Body fat (%) 16.9‡1.8 33.8‡2.1
Waist/hip ratio 0.94‡0.02 1.06‡0.03
HbA1c (%) 5.1‡0.1 6.4‡0.3
Table 1. All subjects participated in sports for no more
than 3 h per week, and none had a physically demanding
job.
The study protocol was reviewed and approved by the
Medical Ethical Review Committee of Maastricht Uni-
versity, and all subjects provided written consent.
Body composition
Body composition was determined by hydrostatic
weighing with simultaneous lung volume measurement
(Volugraph 2000, Mijnhardt, The Netherlands). Body
composition was calculated according to the formula
reported by Siri [15].
Experimental design
The subjects arrived in the laboratory at 8.00 hours, after
an overnight fast. They all came to the laboratory by car
or bus. All subjects were studied while resting supine on
a comfortable bed in a room kept at 23–25 °C. At the
beginning of the experiment two catheters were inserted:
one in the radial artery of the forearm (under local
anaesthetic), and the other in an antecubital vein for the
infusion of the non-selective b-agonist isoprenaline. A
microdialysis probe (see below) was placed sub-
cutaneously under sterile conditions 5–8 cm left from the
umbilicus using a 17 G intravenous catheter as a guide.
The experiment was started 1 h after the insertion of
the cannulae and microdialysis probe. Intermediary
metabolites, arterial and extracellular microdialysate
glycerol concentrations, adipose tissue blood flow (see
below) and whole-body energy expenditure and sub-
strate utilization were studied at rest (1 h period) and
during a 1 h infusion of isoprenaline at a dose of
20 ng[min−"[kg−" fat-free mass. The dose is related to
isoprenaline sulphate, 69% of which corresponds to
isoprenaline free base. Microdialysate was collected in
15 min fractions throughout the 2 h experimental period.
Arterial blood was sampled in the middle of the micro-
dialysis sampling periods, at 22.5, 37.5 and 52.5 min
during both the baseline and the isoprenaline-treatment
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periods. Energy expenditure and substrate utilization
were measured by means of indirect calorimetry through-
out the entire experiment using an open-circuit ventilated
hood system.
Abdominal subcutaneous microdialysis
The subcutaneous microdialysis probes were constructed
of cuprophane fibres (inner diam. 240 lm; wall thickness
50 lm; molecular mass cut-off 20000 Da), obtained from
an artificial kidney (Hospal B. V., Uden, The
Netherlands), as described previously by de Boer and co-
workers [16]. One single fibre (20 mm exposed) was
glued with polyurethane glue (Morton International
G.m.b.H., Bremen, Germany) into polyethylene tubing
(Portex Ltd., Hythe, Kent, U.K. ; 0.80 mm outer diam.
and 0.40 mm inner diam.). A pair of twisted stainless steel
wires (0.06 mm diam.) in the fibre prevented collapse.
The probes were sterilized with ethylene oxide. The
probe was placed subcutaneously under sterile conditions
5–8 cm left from the umbilicus using a 17 G intravenous
catheter as a guide. The polyethylene tubing was perfused
continuously with standard Ringer solution. The probe
membranes were coated with glycerol. For this reason,
the probe was perfused at a high flow rate of 50 ll}min
(Harvard microinfusion pump; Plato b.v., Diemen, The
Netherlands) for the first 1 h after placement, in order to
wash out all the membrane glycerol, after which time the
real experiment was started. In separate pilot experi-
ments, a volume of 2 ml of Ringer solution appeared to
be sufficient to remove the glycerol coating. Following
this initial period, the experiment was started at a
perfusion flow rate of 5 ll}min. Microdialysate was
collected in fractions corresponding to 15 min.
The relative in vivo recovery of glycerol in the
microdialysate was determined individually in an ad-
ditional experiment by means of the equilibrium tech-
nique described by Lo$ nnroth and co-workers [17]. After
an overnight fast, the microdialysis probe was placed
subcutaneously under sterile conditions, as described
above. Four different concentrations of glycerol (0, 75,
150 and 300 lM) were added in turn to the perfusion
fluid (each concentration for 1 h). The net changes in
dialysate glycerol were determined. Regression analysis
of the net change in dialysate glycerol against the ingoing
glycerol concentration showed a good linear correlation
during the calibration period (all experiments : r " 0.85).
The glycerol concentration that resulted in no net change
in dialysate glycerol was assumed to correspond to the
actual extracellular glycerol concentration.
Measurement of adipose tissue blood flow
133Xe-washout method
Subcutaneous adipose tissue blood flow was measured
using the "$$Xe-washout method on the abdomen a little
distal and lateral to the umbilicus (near the microdialysis
probe), as described previously [6,18]. From the re-
gression of count rate against time, the rate of dis-
appearance of "$$Xe (injected dose 5.5 MBq, dissolved in
saline) was determined over the last 30 min of the resting
period and during an early (from 10 to 30 min) and late
phase (from 30 to 60 min) of the isoprenaline infusion.
Tissue–blood partition coefficient
Adipose tissue blood flow can be calculated by mul-
tiplying the disappearance constant for xenon by the
partition coefficient for the distribution of xenon be-
tween the adipose tissue and blood. Thus, for the
calculation of quantitative values of adipose tissue blood
flow (per 100 g of tissue), the relative solubility of xenon
between tissue and blood, i.e. the partition coefficient,
must be known. We calculated the tissue–blood partition
coefficient on an individual basis, taking into account the
lipid content of adipose tissue, the haematocrit, and the
solubility of xenon in blood, red blood cells, adipose
tissue, lipid and plasma [19,20], as described in detail
previously [6].
Biochemical analyses
For the determination of arterial concentrations of
glycerol, NEFA, glucose and insulin, blood was taken
into syringes containing EDTA. Plasma NEFA, glucose
and glycerol were measured using standard enzymic
techniques automated on a Cobas Farah centrifugal
analyser at 340 nm (NEFA, NEFA c, Wako Chemicals,
Neuss, Germany; glucose, Roche Diagnostics, Hoffman-
La Roche, Basel, Switzerland; glycerol, Boehringer,
Mannheim, Germany). Microdialysate glycerol was de-
termined fluorimetrically on the Cobas Farah with the
same standard enzymic assay, but with adapted concen-
trations of NAD+, enzymes and buffer to achieve
accurate fluorimetric detection. The detection limit of
this assay was 10 lM. Plasma insulin was measured by a
specific double-antibody radioimmunoassay for human
insulin (Kabi Pharmacia Diagnostics, Uppsala, Sweden).
Urine was collected overnight and at the end of the
experiment for the determination of urinary nitrogen, in
order to calculate the non-protein respiratory exchange
ratio, as well as carbohydrate and fat oxidation (see
below).
Calculations
Glycerol release
Glycerol release across adipose tissue
(lmol[min−"[100 g−" adipose tissue) was calculated ac-
cording to Fick’s equation, as described previously
[21,22] :
Glycerol release fl (AfiV)}100‹ATBF‹(1fiHt}100)
where A is the arterial plasma glycerol concentration
(lmol}l), V is the capillary venous plasma glycerol
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concentration (lmol}l), Ht is the haematocrit, and ATBF
is adipose tissue blood flow (ml[min−"[100 g−" adipose
tissue). Conversion of interstitial into capillary venous
plasma substrate concentration was performed using the
equation:
V fl (IfiA)‹(1fie−PS/Q)›A
where V is the capillary venous substrate concentration,
I is the interstitial substrate concentration, A is the
arterial substrate concentration, PS is permeability sur-
face product area for glycerol (‡5 ml[min−"[100 g−")
[22–24] and Q is adipose tissue plasma flow rate.
Gas exchange monitoring
The metabolic rate was calculated from O
#
consumption
(VO
#
) and CO
#
production (VCO
#
) according to the
equation of Weir [25]. Carbohydrate and fat oxidation
rates were calculated from VO
#
and VCO
#
and urinary
nitrogen excretion. The amount of protein oxidized was
estimated from total nitrogen excretion, since most
urinary nitrogen (" 80%) is in the form of urea, with 1 g
of nitrogen arising from approx. 6.25 g of protein. Rates
of carbohydrate and fat oxidation were calculated using
values for gas exchange from the table reported by Frayn
[26].
Statistical analysis
Results are presented as means‡S.E.M. To compare
responses between and within groups, a two-factor
repeated-measures analysis of variance (ANOVA) was
performed. A P value of ! 0.05 was regarded as statis-
tically significant.
RESULTS
Interstitial and arterial glycerol
concentrations
As described in the Methods section, adipose tissue
extracellular glycerol concentrations were calculated by
determining the ingoing glycerol concentration that
resulted in no net change in dialysate glycerol con-
centration. The resting adipose tissue extracellular
concentrations were 170‡11 lmol}l in control subjects
and 279‡34 lmol}l in subjects with type II diabetes
(P ! 0.01). The in vivo recovery of the microdialysis
probes was 18‡3% in control subjects and 17‡4% in
subjects with type II diabetes. In both groups there was a
decrease in the interstitial glycerol concentration as result
of isoprenaline infusion (repeated measures, P ! 0.001;
Figure 1). Interstitial glycerol levels remained higher
throughout the experiment in subjects with type II
diabetes compared with controls (group effect, P ! 0.01).
Arterial glycerol concentrations were higher in subjects
with type II diabetes than in controls, both during rest
and during isoprenaline infusion (group effect, P ! 0.05),
whereas the increases in arterial glycerol concentration as
a result of isoprenaline infusion (group effect, P ! 0.001)
were of a similar magnitude in the two groups (Figure 1).
The arterial–interstitial concentration difference tended
to be higher in subjects with type II diabetes than in
control subjects (P fl 0.0507), and this difference
decreased in both groups during isoprenaline infusion
(repeated measures, P ! 0.001).
Adipose tissue blood flow
On the basis of a previously described equation [6], the
partition coefficient for xenon between adipose tissue
and blood was calculated, and this amounted to 6.1‡0.2
in control subjects and 8.2‡0.2 in subjects with type II
diabetes. Basal blood flow values (0.77‡0.48 and
2.04‡0.37 ml[min−"[100 g−" respectively) and iso-
prenaline-induced increases in blood flow (repeated
measures, P ! 0.01) were not significantly different
between the groups (Figure 1). The estimated sub-
cutaneous adipose tissue glycerol release was not signifi-
cantly different between groups, both during baseline
conditions and during isoprenaline treatment (Figure 2).
Isoprenaline infusion increased glycerol release in both
groups (repeated measures, P ! 0.05).
Arterial insulin, glucose and NEFA
concentrations
Figure 3 shows values for arterial insulin, glucose and
NEFA concentrations throughout the experiment. The
basal insulin concentration and the isoprenaline-induced
increase in insulin concentration were higher in subjects
with type II diabetes compared with controls (group
effect, P ! 0.01; interaction: group‹repeated measures,
P ! 0.02). Glucose concentrations were higher in sub-
jects with type II diabetes than in control subjects
throughout the experiment (group effect, P ! 0.01),
whereas the glucose concentration decreased significantly
during isoprenaline treatment in subjects with type II
diabetes, but remained stable in control subjects (in-
teraction: group‹repeated measures, P ! 0.05). Basal
NEFA concentrations were comparable in both groups,
whereas the isoprenaline-induced increase in NEFA
concentration tended to be blunted in subjects with type
II diabetes (Figure 3; interaction: group‹repeated
measures, P fl 0.10).
Energy expenditure and substrate
utilization
Figure 4 shows values for energy expenditure, carbo-
hydrate oxidation and fat oxidation, expressed per kg fat-
free mass, in both groups. After 10 min of isoprenaline
infusion, a steady state for energy expenditure was
reached, i.e. values at 5 min did not change significantly
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Figure 1 Abdominal subcutaneous adipose tissue arterial and interstitial glycerol concentrations and blood flow during
60 min of intravenous isoprenaline infusion in obese subjects with type II diabetes and in non-obese controls
Results of ANOVA are indicated in the text.
Figure 2 Abdominal subcutaneous adipose tissue glycerol
release during rest and after 30 and 60 min of intravenous
isoprenaline infusion in obese subjects with type II diabetes
and in non-obese controls
Open bars, controls ; filled bars, subjects with type II diabetes. A negative value
indicates release. Results of ANOVA are indicated in the text.
until the end of the infusion. For the respiratory exchange
ratio, carbohydrate oxidation and fat oxidation, a steady
state was reached after 20 min of isoprenaline infusion.
The final 30 min of the isoprenaline infusion period were
taken as being representative of the responses for both
energy expenditure and substrate utilization. Absolute
basal values for energy expenditure were significantly
higher in subjects with type II diabetes compared with
control subjects (5.9‡0.3 and 5.1‡0.2 kJ}min respect-
ively; P ! 0.05). Basal energy expenditure expressed
per kg fat-free mass or corrected for fat-free mass by
means of analysis of covariance was not significantly
different between groups. Isoprenaline-induced thermo-
genesis was comparable in the two groups, irrespective of
whether it was expressed as increase per kg fat-free mass
(Figure 4) or as percentage increase above baseline (type
II diabetes, 14.0‡1.8%; controls, 15.9‡2.2%). Values
for fat oxidation were not significantly different between
the two groups. The isoprenaline-induced increase in fat
oxidation (absolute or per kg fat free mass ; P ! 0.01) was
less pronounced in subjects with type II diabetes than in
control subjects (Figure 4; interaction: group‹repeated
measures, P fl 0.058), resulting in similar values for fat
oxidation in the two groups during isoprenaline infusion.
Values for carbohydrate oxidation (absolute or
expressed per kg fat-free mass) were not significantly
different between the two groups (group effect, P fl
0.11). The decrease in carbohydrate oxidation as a result
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Figure 3 Arterial insulin, glucose and NEFA concentrations
during 60 min of intravenous isoprenaline infusion in obese
subjects with type II diabetes and in non-obese controls
*, Controls ; V, D, subjects with type II diabetes. Results of ANOVA are
indicated in the text.
of isoprenaline infusion tended to be less pronounced in
subjects with type II diabetes compared with controls,
but differences between groups were not significant.
Values for the respiratory exchange ratio at rest were
significantly lower in subjects with type II diabetes than
in control subjects (0.79‡0.01 and 0.83‡0.01 respect-
ively; P ! 0.01), whereas the isoprenaline-induced de-
crease in the respiratory exchange ratio tended to be
blunted in subjects with type II diabetes (type II diabetes,
0.76‡0.01; controls, 0.77‡0.01) (interaction: group
‹isoprenaline, P fl 0.0795).
Figure 4 Whole-bodyenergy expenditure, and carbohydrate
and fat oxidation during rest and in steady-state conditions
during 60 min of intravenous isoprenaline infusion in obese
subjects with type II diabetes and in non-obese controls
Open bars, controls ; filled bars, subjects with type II diabetes. ISO, isoprenaline ;
EE, energy expenditure ; FFM, fat-free mass. Results of ANOVA are indicated in the
text.
DISCUSSION
Previous studies have found impaired lipolysis and fat
oxidation during stimulation by catecholamines in obese
males [4,5,8,9]. The impaired lipolysis was accompanied
by a lowered blood flow response during stimulation of
the b-adrenoceptors, indicating that blood flow may be
of importance in the regulation of fat mobilization
[6]. These disturbances may be important in the de-
velopment of a positive fat balance (i.e. fat intake exceeds
fat utilization), obesity and insulin resistance [11]. The
present study was intended to investigate whether similar
mechanisms are operative in obese subjects with type II
diabetes. The major finding of the present study is that b-
adrenergically mediated lipolysis, as reflected by arterial
glycerol concentrations and estimated local abdominal
subcutaneous glycerol release, is normal in obesity-
associated type II diabetes.
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Methodological considerations
First, a comparison of glycerol release values estimated
from microdialysis and the arteriovenous technique
yielded on average 40% lower values with the former
compared with the latter technique. This may be partly
caused by the assumptions for the permeability surface
product that are made in calculating venous plasma
values from interstitial glycerol values. Additionally,
microdialysis may reflect intracellular lipolysis rather
than intravascular lipolysis [27]. Thus it must be stressed
that quantitative values for local glycerol release have to
be interpreted with caution.
Secondly, for calculating quantitative blood flow
values from the "$$Xe-washout curves, the adipose-
tissue–blood partition coefficient must be known. The
highest solubility coefficients for Xe are found for lipids
and haemoglobin, which implies that the lipid content of
adipose tissue and the haematocrit of the blood perfusing
it will be major determinants of the partition coefficient.
For this reason, we calculated the tissue–blood partition
coefficient on an individual basis, taking into account the
lipid content of adipose tissue, the haematocrit and the
solubility of Xe in blood, red blood cells, adipose tissue,
lipid and plasma [19,20], as described in detail previously
[6]. Notably, the use of similar values for the partition
coefficient in the two groups would not alter the
conclusions of the present study with respect to the rate
of glycerol release.
Indicators of lipolysis and blood flow
Both estimated local subcutaneous abdominal lipolysis,
as studied by microdialysis, and the circulating arterial
glycerol concentration showed increases of similar mag-
nitude during isoprenaline infusion in subjects with type
II diabetes and controls, indicating normal isoprenaline-
induced lipolysis in obesity-associated type II diabetes.
This was accompanied by a normal isoprenaline-induced
increase in adipose tissue blood flow. The above findings
are in contrast with previous data from our laboratory
obtained with obese subjects [4–6], studied under com-
parable experimental conditions, where isoprenaline-
induced lipolysis and blood flow responses appeared to
be blunted [obese subjects in previous study compared
with obese type II diabetic subjects in the present study:
change in arterial glycerol, 18‡12 and 53‡9 lmol}l
respectively (P ! 0.05) ; change in blood flow response,
2.7‡0.9 and 6.1‡1.1 mmol}l respectively (P ! 0.05)].
Thus these findings indicate that the relative importance
of processes involved in lipid mobilization may differ in
obesity and obesity-associated type II diabetes.
The finding of normal glycerol release in abdominal
subcutaneous adipose tissue of subjects with type II
diabetes seems to contrast with the observations of
Reynisdottir and co-workers [2], which showed a re-
sistance of lipolysis to stimulation by catecholamines
(defect in b
#
-adrenoceptor mRNA expression) [2,28] in
subcutaneous adipocytes from upper-body-obese males
with insulin resistance or type II diabetes. Possible
explanations for this apparent discrepancy may lie in the
fact that the latter data were obtained from in vitro
experiments, and cannot be extrapolated to lipolysis in
vivo (i.e. the importance of blood flow in the regulation
of lipid mobilization), or may lie in differences in the
characteristics of the subjects : our subjects had no other
health complications apart from their type II diabetes,
whereas the subjects in the study of Reynisdottir et al. [2]
had other health complications characteristic of the
insulin resistance syndrome. Further (in vivo) research is
neccessary in order to elucidate the factors involved in
deviations in lipid mobilization in conditions such as
obesity, insulin resistance and obesity-associated type II
diabetes.
Fat oxidation
During increased b-adrenergic stimulation the obese
diabetic subjects tended to have a blunted increase in fat
oxidation, as reported previously in abdominally obese
subjects [8,9] and in obese subjects with type II diabetes
[10]. These data suggest that obese subjects with type II
diabetes have a diminished ability to increase the
utilization of fat as a fuel under conditions where the
energy demands of the body are increased. The
diminished capacity to increase fat oxidation may poss-
ibly contribute to the development of a positive fat
balance, and consequently provide a link between obesity
and type II diabetes by promoting (abdominal) obesity
and insulin resistance.
Estimated basal lipolysis
Increased glycerol release from adipose tissue in the
resting state has been indicated as a risk factor in the
aetiology of hyperglycaemia, by providing carbon
skeletons for gluconeogenesis to the liver, thereby stimu-
lating hepatic gluconeogenesis and hepatic glucose output
[14]. The present study shows that, although systemic
arterial glycerol concentrations are increased in type II
diabetes, indicating greater whole-body lipolysis, esti-
mated glycerol release from subcutaneous adipose tissue,
expressed per unit fat mass, is not significantly different
from that in control subjects. These findings correspond
with results from Jansson and co-workers, who pre-
viously reported a normal lipolytic response per unit fat
mass in obese subjects [21] and in obese subjects with
type II diabetes [22].
Thermogenesis
As discussed elsewhere [10], the thermogenic response in
subjects with type II diabetes was comparable with that
in control subjects, in agreement with previous data in
obese subjects, indicating that a diminished b-
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adrenoceptor-mediated thermogenic response is not
involved in the maintenance and}or aetiology of obesity
in type II diabetes.
Conclusion
In conclusion, b-adrenergically mediated blood flow
responses and indicators of lipolysis are normal in obese
subjects with type II diabetes, which contrasts with
previous data obtained using obese non-diabetic subjects.
This indicates that processes involved in lipid
mobilization may differ in obesity and obesity-associated
type II diabetes.
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